CSG’s €25 Billion Ambition Collides With a 52-Week Low

The Czechoslovak Group (CSG) is charting an aggressive course toward a €25 billion valuation via an accelerated listing in Amsterdam, yet its shares are plumbing depths that tell a starkly different story. On Friday, the ammunition manufacturer’s stock touched a new 52-week low of €19.93, shedding 6.6% in a single session. Over the past month, the decline has accelerated to nearly 31%, dragging the shares far below their 50-day moving average and underscoring the severity of the downward trajectory.

A Market Leader Trading at a Discount

CSG operates as Europe’s second-largest producer of medium- and large-caliber ammunition and claims the top spot globally in small-caliber revenue. Its production facilities serve government and civilian clients in more than 70 countries, and the structural tailwinds from sustained NATO defense spending have kept order books bulging. The company’s backlog currently stands at roughly €15 billion, providing multiyear revenue visibility.

That operational heft, however, has done little to shield the stock from a brutal selloff. From its January high near €34, the share price has collapsed, creating a yawning gap between the company’s market standing and its valuation. Analysts see this as a clear overreaction. The consensus price target from over a dozen analysts sits at approximately €35.50, implying upside of more than 75% from current levels. A handful of experts have set targets as high as €42.

Record Earnings, Yet Skepticism Reigns

The disconnect is all the more puzzling given CSG’s financial performance. Net profit for the last fiscal year surged 35% to €870 million, while annual revenue climbed to €6.7 billion. The company is also forecasting robust growth ahead: analysts expect earnings to expand by nearly 22% annually over the coming years, comfortably outpacing the broader Dutch market. Revenue is projected to rise at a double-digit percentage clip each year.

Should investors sell immediately? Or is it worth buying CSG?

Management is doubling down on high-margin products, particularly 155-millimeter artillery shells, and has bolstered its portfolio through bolt-on acquisitions in Italy and Austria. Yet the market remains unconvinced, punishing the stock even as fundamentals improve.

A Landmark Listing With Heavyweight Backing

To fund its Amsterdam listing, CSG plans to issue new shares worth around €750 million, while an existing shareholder will also sell down a stake. The combined capital-raising effort could exceed €3 billion, which would set a record for European defense-sector equity placements this year.

The offering has already attracted blue-chip investors. BlackRock, Cornerstone Artisan Partners, and a subsidiary of the Qatar Investment Authority have committed a combined €900 million to the placement. A banking consortium led by JPMorgan and BNP Paribas is managing the transaction.

Upcoming Catalysts

Investors will get their next look at the company’s trajectory on May 19, 2026, when CSG releases a first-quarter business update. A detailed earnings report follows on June 3. Those disclosures will test whether management can translate its strong operational momentum into numbers that satisfy both the analysts’ lofty projections and the market’s current skepticism. For now, the stock’s slide stands in sharp contrast to the company’s ambitions — and the €25 billion valuation it is chasing.